144 related articles for article (PubMed ID: 16987643)
41. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
[TBL] [Abstract][Full Text] [Related]
42. New and emerging prophylactic agents for migraine.
Krymchantowski AV; Bigal ME; Moreira PF
CNS Drugs; 2002; 16(9):611-34. PubMed ID: 12153333
[TBL] [Abstract][Full Text] [Related]
43. Butterbur: an evidence-based systematic review by the natural standard research collaboration.
Giles M; Ulbricht C; Khalsa KP; Kirkwood CD; Park C; Basch E;
J Herb Pharmacother; 2005; 5(3):119-43. PubMed ID: 16520304
[TBL] [Abstract][Full Text] [Related]
44. Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials.
Damen L; Bruijn J; Verhagen AP; Berger MY; Passchier J; Koes BW
Cephalalgia; 2006 May; 26(5):497-505. PubMed ID: 16674757
[TBL] [Abstract][Full Text] [Related]
45. Extract matrix composition does not affect in vitro leukotriene inhibitory effects of the Petasites hybridus extract Ze 339.
Kodjadjiku U; Nägele B; Halbsguth C; Butterweck V
Fitoterapia; 2021 Sep; 153():104986. PubMed ID: 34252512
[TBL] [Abstract][Full Text] [Related]
46. Symptomatic treatment of migraine in children: a systematic review of medication trials.
Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
[TBL] [Abstract][Full Text] [Related]
47. A quantification of the placebo response in migraine prophylaxis.
van der Kuy PH; Lohman JJ
Cephalalgia; 2002 May; 22(4):265-70. PubMed ID: 12100088
[TBL] [Abstract][Full Text] [Related]
48. Flunarizine in migraine prophylaxis: the clinical experience.
Schmidt R; Oestreich W
J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S21-6. PubMed ID: 1726732
[TBL] [Abstract][Full Text] [Related]
49. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
Shrivastava R; Pechadre JC; John GW
Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
[TBL] [Abstract][Full Text] [Related]
50. Homeopathic prophylaxis of headaches and migraine? A systematic review.
Ernst E
J Pain Symptom Manage; 1999 Nov; 18(5):353-7. PubMed ID: 10584459
[TBL] [Abstract][Full Text] [Related]
51. Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptido-leukotriene synthesis.
Brune K; Bickel D; Peskar BA
Planta Med; 1993 Dec; 59(6):494-6. PubMed ID: 8302945
[TBL] [Abstract][Full Text] [Related]
52. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
54. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
55. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339.
Schapowal A;
Phytother Res; 2005 Jun; 19(6):530-7. PubMed ID: 16114089
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of Pinus radiata bark extract and vitamin C combination product as a prophylactic therapy for recalcitrant migraine and long-term results.
Chayasirisobhon S
Acta Neurol Taiwan; 2013 Mar; 22(1):13-21. PubMed ID: 23479241
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous determination of sesquiterpenes and pyrrolizidine alkaloids from the rhizomes of Petasites hybridus (L.) G.M. et Sch. and dietary supplements using UPLC-UV and HPLC-TOF-MS methods.
Avula B; Wang YH; Wang M; Smillie TJ; Khan IA
J Pharm Biomed Anal; 2012 Nov; 70():53-63. PubMed ID: 22809670
[TBL] [Abstract][Full Text] [Related]
58. Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract.
Anderson N; Borlak J
J Clin Med; 2019 May; 8(5):. PubMed ID: 31083451
[TBL] [Abstract][Full Text] [Related]
59. Foods and supplements in the management of migraine headaches.
Sun-Edelstein C; Mauskop A
Clin J Pain; 2009 Jun; 25(5):446-52. PubMed ID: 19454881
[TBL] [Abstract][Full Text] [Related]
60. Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus.
Bickel D; Röder T; Bestmann HJ; Brune K
Planta Med; 1994 Aug; 60(4):318-22. PubMed ID: 7938265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
